PRL and cancer: According to the p value, the AGE-RAGE signalling pathway in diabetic complications, Kaposi sarcoma-associated herpesvirus infection, proteoglycans in cancer, endocrine resistance, hepatitis B, the IL-17 signalling pathway, prostate cancer, the prolactin signalling pathway, human cytomegalovirus infection, pancreatic cancer, the HIF-1 signalling pathway, and EGFR tyrosine kinase inhibitor resistance were within the top 12 terms.